Advisory Committee

Teri Bedard is the Executive Director of Client & Corporate Resources with Revenue Cycle Coding Strategies (RCCS). With more than 20 years of medical experience, Teri has served as the senior and staff radiation therapist at renowned oncology practices across the Midwest. During her tenure with RCCS, Teri has served as Senior Consultant, Remote Solutions Manager, and Director of Client Services. At RCCS, Teri advises and leads clients in billing and reimbursement for technology, monitoring government regulatory information and seeking new business opportunities.

Teri earned her BA at the University of Northern Iowa; completed her radiologic technology certificate at Mayo School for Health-Related Sciences in Rochester, MN; and earned a certificate in radiation therapy from Fairview University Medical Center in Minneapolis, MN. Teri is certified as a professional coder through the American Academy of Professional Coders.

Jennifer C. King, PhD, is the Chief Scientific Officer for the GO2 Foundation for Lung Cancer. She is a cancer research scientist turned patient advocate who offers a unique perspective: striking a balance between understanding the impact and mechanisms of new treatments and being able to explain what it all means to the greater cancer community. She uses her training to lead cutting-edge research initiatives to improve the lives of those living with or at risk for lung cancer.

As a translational oncology researcher, Dr. King has studied new molecular targets for cancer therapeutics and developed oncology mouse models at Memorial Sloan-Kettering Cancer Center and the Jonsson Comprehensive Cancer Center at UCLA. She has worked in the nonprofit space for more than a decade, overseeing Conquer Cancer Foundation's research grant programs and portfolios, working in health IT and data governance for CancerLinQ,® and co-founding a patient-facing health data-sharing nonprofit, SHARE& For Cures.

Dr. King serves on multiple advisory boards and workgroups for national organizations such as the American Society of Clinical Oncology, the Agency for Healthcare Research and Quality, the Association of Community Cancer Centers, the National Lung Cancer Roundtable, and various pharmaceutical and diagnostics companies.

Dr. King earned a PhD in biology from the Massachusetts Institute of Technology and a BS from Duke University. She is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer.